Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Neurotoxicology. 2016 Sep 20;57:112–120. doi: 10.1016/j.neuro.2016.09.011

Figure 3.

Figure 3

Complex IV activity following MZ treatment. Following acute treatment with 7.5% or 17.0% MZ a statistically significant increase in absorbance associated with DAB conversion was measured. Data are presented as mean absorbance + SEM and represent N ≥ 4 separate synchronizations. *p < 0.05, ***p < 0.001 compared to control.